|
TMEM66 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23698837231723E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03740357918036E-11 |
| Normal-vs-Stage2 |
4.901300E-03 |
| Normal-vs-Stage3 |
1.887810E-02 |
| Normal-vs-Stage4 |
5.074400E-02 |
| Stage1-vs-Stage2 |
5.211800E-01 |
| Stage1-vs-Stage3 |
9.485900E-02 |
| Stage1-vs-Stage4 |
9.027200E-01 |
| Stage2-vs-Stage3 |
4.582000E-01 |
| Stage2-vs-Stage4 |
7.569200E-01 |
| Stage3-vs-Stage4 |
3.751400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.4624746686186E-12 |
| Normal-vs-AfricanAmerican |
1.26410000000909E-06 |
| Normal-vs-Asian |
2.412600E-01 |
| Caucasian-vs-AfricanAmerican |
5.507800E-01 |
| Caucasian-vs-Asian |
8.987600E-01 |
| AfricanAmerican-vs-Asian |
8.076000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62947433324234E-12 |
| Normal-vs-Female |
2.061700E-03 |
| Male-vs-Female |
8.199100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.79299999999838E-05 |
| Normal-vs-Extreme_Weight |
2.09689998698082E-09 |
| Normal-vs-Obese |
1.37249999998534E-06 |
| Normal-vs-Extreme_Obese |
8.156600E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.610800E-01 |
| Normal_Weight-vs-Obese |
6.688200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.906400E-01 |
| Extreme_Weight-vs-Obese |
2.404800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.531200E-01 |
| Obese-vs-Extreme_Obese |
1.304780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.593500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.00699999450171E-08 |
| Normal-vs-Age(61-80Yrs) |
4.91828799908944E-14 |
| Normal-vs-Age(81-100Yrs) |
8.016100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.361400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.227200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.418000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.122600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.243200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.022200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
5.157100E-04 |
| Normal-VS-KIRP CIMP |
6.277800E-01 |
| Normal-VS-Unclassified PRCC |
4.47089999999761E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.414300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.776400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.479800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.650400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.838600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.176150E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.69159999999324E-06 |
| Normal-vs-N1 |
6.816600E-03 |
| Normal-vs-N2 |
8.822200E-01 |
| N0-vs-N1 |
5.682600E-01 |
| N0-vs-N2 |
2.213400E-01 |
| N1-vs-N2 |
3.765800E-01 |
|
|
